Correlation Between Acrivon Therapeutics, and Tempest Therapeutics
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Tempest Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Tempest Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and Tempest Therapeutics, you can compare the effects of market volatilities on Acrivon Therapeutics, and Tempest Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Tempest Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Tempest Therapeutics.
Diversification Opportunities for Acrivon Therapeutics, and Tempest Therapeutics
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Acrivon and Tempest is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Tempest Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempest Therapeutics and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Tempest Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempest Therapeutics has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Tempest Therapeutics go up and down completely randomly.
Pair Corralation between Acrivon Therapeutics, and Tempest Therapeutics
Given the investment horizon of 90 days Acrivon Therapeutics, Common is expected to under-perform the Tempest Therapeutics. In addition to that, Acrivon Therapeutics, is 1.22 times more volatile than Tempest Therapeutics. It trades about -0.03 of its total potential returns per unit of risk. Tempest Therapeutics is currently generating about 0.06 per unit of volatility. If you would invest 92.00 in Tempest Therapeutics on September 1, 2024 and sell it today you would earn a total of 3.00 from holding Tempest Therapeutics or generate 3.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acrivon Therapeutics, Common vs. Tempest Therapeutics
Performance |
| Timeline |
| Acrivon Therapeutics, |
| Tempest Therapeutics |
Acrivon Therapeutics, and Tempest Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acrivon Therapeutics, and Tempest Therapeutics
The main advantage of trading using opposite Acrivon Therapeutics, and Tempest Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Tempest Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempest Therapeutics will offset losses from the drop in Tempest Therapeutics' long position.| Acrivon Therapeutics, vs. Aerovate Therapeutics | Acrivon Therapeutics, vs. Adagene | Acrivon Therapeutics, vs. Rezolute | Acrivon Therapeutics, vs. AN2 Therapeutics |
| Tempest Therapeutics vs. Indaptus Therapeutics | Tempest Therapeutics vs. Rezolute | Tempest Therapeutics vs. Forte Biosciences | Tempest Therapeutics vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |